Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.
about
Prophylactic implantable cardioverter defibrillator in heart failure: the growing evidence for all or Primum non nocere for some?Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.Predictors of serious arrhythmic events in patients with nonischemic heart failure.Development of ventricular fibrillation after implantation of a biventricular implantable cardioverter defibrillator: what is the mechanism?European Society of Cardiology congress update, Rome, 27-31 August 2016.Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction.Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials.Wearable cardioverter defibrillator: Bridge or alternative to implantation?Recent advances in the management of ventricular tachyarrhythmias.Advances in Clinical Cardiology 2016: A Summary of the Key Clinical Trials.ECG-derived spatial QRS-T angle is associated with ICD implantation, mortality and heart failure admissions in patients with LV systolic dysfunction.[3-D mapping of ventricular tachycardia in patients with dilative cardiomyopathy].Genetics and genomics of dilated cardiomyopathy and systolic heart failure.Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillatorGender-adjusted and age-adjusted economic inpatient burden of congestive heart failure: cost and disability-adjusted life-year analysis.Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future.Primary prevention implantable cardioverter defibrillator in patients with non-ischaemic cardiomyopathy: a meta-analysis of randomised controlled trials.Role of implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a systematic review and meta-analysis of prospective randomized clinical trials.Increasing sex differences in the use of cardiac resynchronization therapy with or without implantable cardioverter-defibrillator.Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey.Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis.Arrhythmic risk stratification in heart failure: Time for the next step?Technologies for Prolonging Cardiac Implantable Electronic Device Longevity.Prevention of Cardiac Implantable Electronic Device Infections: Single Operator Technique with Use of Povidone-Iodine, Double Gloving, Meticulous Aseptic/Antiseptic Measures and Antibiotic Prophylaxis.Implantable cardioverter/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and systematic review of randomized controlled trials.Sudden death risk stratification in non-ischemic dilated cardiomyopathy using old and new tools: a clinical challenge.The effects of gender on electrical therapies for the heart: procedural considerations, results and complications: A report from the XII Congress of the Italian Association on Arrhythmology and Cardiostimulation (AIAC).The effects of gender on electrical therapies for the heart: physiology, epidemiology, and access to therapies: A report from the XII Congress of the Italian Association on Arrhythmology and Cardiostimulation (AIAC).Implantable Cardioverter Defibrillator for the Primary Prevention of Sudden Cardiac Death in Patients With Nonischemic Cardiomyopathy.Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications.Cause-of-death analysis in patients with cardiac resynchronization therapy with or without a defibrillator: a systematic review and proportional meta-analysis.Sudden cardiac death in nonischemic cardiomyopathy: Refining risk assessment.Rationales and choices for the treatment of patients with NYHA class II heart failure.Novel Pacing Strategies for Heart Failure Management.Heart failure with reduced ejection fraction.Shocks after implantable cardioverter-defibrillator implantation in idiopathic cardiomyopathy patients: a myocardial biopsy study.Temporal Trends Over a Decade of Defibrillator Therapy for Primary Prevention in Community Practice.[Sudden cardiac death : Epidemiology, pathophysiology and risk stratification].Identifying patients with less potential to benefit from implantable cardioverter-defibrillator therapy: comparison of the performance of four risk scoring systems.Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
P2860
Q30235600-247C5883-05EC-4F18-A577-5E4FFBEAD7BCQ30252338-1CEC991D-C050-4DFF-8053-3CCB62F6E53DQ33167997-508FAB2A-F487-4008-BDBA-6BF44829C469Q33168847-47C53BA6-6D91-4F3A-B34C-E30C4EB94DA0Q33615196-3EFDED01-0774-46AC-9C7D-6DDB522E486DQ33727302-519CFEC5-04CF-4A8D-BF94-0E38EDE0ED7BQ33770849-F29B4B76-17A1-4116-9A39-0B721EB015FAQ33854130-FB431704-E056-4524-A97B-99CDAFE05F25Q33873348-5A59986B-B992-4A11-B513-6ABCCFAA80C0Q33890811-5066164A-0A4C-495D-A9C5-6A887677DE61Q36328047-EBD90452-2ABB-4575-80C3-B0CE6E5D108CQ36396499-133BC78A-B775-47F9-9EE1-319D3FE4F743Q37661546-7E0EDBF5-C56C-43C3-98D8-59E7FA68904CQ38635591-9F426D95-26ED-4886-B9AD-09BA14606C30Q38647517-BD9F5003-CBC6-4E4E-B3B8-FA15FD802DAAQ38659406-A97C9478-6F38-47B5-BF21-A864DD281472Q38668314-015EF655-22E7-4E9A-A63C-90B62ECE1884Q38694901-92E0C65C-E790-48AE-A3AD-23B3930097F2Q38773248-4DAEB3DB-78C7-41CB-A3DB-3FE127DCD047Q38826493-AB6FEB29-914C-4788-B965-1F1AD77A8646Q38868952-DCCE5EE3-B302-4E72-B17D-A468287415BFQ38933864-6E263AFC-1F40-449D-9A0B-9A00F56FC988Q39036267-04633586-0239-4FE4-8D07-6B154ECDBEB2Q39084453-30B1647C-F4C0-4101-94F9-C4A7D69F606DQ39141583-C1AC939B-23B7-452E-98F2-CC2F3152F89CQ39177912-3927A1F0-7055-46D4-9827-2110602E5EDAQ39315683-4CD555AA-EA8A-46E1-9158-11641B331EADQ39318361-5A822A91-2CC4-4940-BC98-56018E5C6E07Q39336164-95CEB722-268C-4874-AC9A-566DC67A3BCCQ39388903-C94B11E8-4BF0-459C-A27E-290A4814E449Q39407493-77ABA661-7383-42DD-A934-8837C833836AQ39410638-BF8844ED-2CEA-418F-B250-DA51CAE02FD5Q39410727-A56302C5-38BA-4C3A-BCD9-764D7E435198Q39451518-5B218457-19B6-476F-9C0C-9DBEA2191C93Q40081533-34381A7E-FF8E-4538-9C74-BFE9DF24476AQ40082981-DD61D3D9-EF62-4710-83B3-0D4D820B7264Q40311907-1BE15745-3F47-4A8F-BD9B-96E58669A01BQ40322741-27908B7E-4BA0-408B-8903-A1AF11629E90Q41051372-2FE4E601-B728-4583-8D90-8F90DAD0FA41Q41101756-38397AB1-DEA2-4E50-889D-F70966572FC7
P2860
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.
@en
type
label
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.
@en
prefLabel
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.
@en
P2093
P50
P356
P1476
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.
@en
P2093
Anna M Thøgersen
Axel Brandes
DANISH Investigators
Dan E Høfsten
Finn Gustafsson
Gunnar Jensen
Hans Eiskjær
Jens C Nielsen
Jens Haarbo
P304
P356
10.1056/NEJMOA1608029
P407
P50
P577
2016-08-27T00:00:00Z